Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03670056
Title A Pilot Study of Combination Immunotherapy With Ipilimumab and Nivolumab in Patients With Recurrent Extensive Stage Small Cell Lung Cancer (SCLC) Who Have Previously Received Platinum-based Chemotherapy
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Yale University
Indications

lung small cell carcinoma

Therapies

Ipilimumab + Nivolumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Yale University, Yale Cancer Center New Haven Connecticut 06510 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field